Symbol="KNTE"
AssetType="Common Stock"
Name="Kinnate BiopharmaÂ Inc"
Description="Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. The company is headquartered in San Diego, California."
CIK="1797768"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11975 EL CAMINO REAL, STE 101, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="135526000"
EBITDA="-125366000"
PERatio="None"
PEGRatio="None"
BookValue="4.783"
DividendPerShare="0"
DividendYield="0"
EPS="-2.36"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.266"
ReturnOnEquityTTM="-0.442"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="21.06"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.063"
EVToRevenue="-"
EVToEBITDA="-0.336"
Beta="-0.0208"
num_52WeekHigh="15.86"
num_52WeekLow="2.32"
num_50DayMovingAverage="3.421"
num_200DayMovingAverage="5.59"
SharesOutstanding="46572600"
DividendDate="None"
ExDividendDate="None"
symbol="KNTE"
open="2.85"
high="3.01"
low="2.84"
price="2.91"
volume="136831.00"
latest_trading_day="2023-07-28"
previous_close="2.85"
change="0.06"
change_percent="2.1053%"
aroon_positive_momentum_days="10"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="10"
Volume_recent_avg="418760"
Change_recent_avg="-0.04"
Delta_recent_avg="0.41"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-1.39"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="10"
Aroon_momentum_negative="90"
image_negative_thumbnail_id_1="122"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0054.jpeg"
image_negative_thumbnail_id_2="108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="656"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_positive_thumbnail_id_2="678"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0030.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
